Quick Answer
IGC Pharma, Inc. reported Total Assets of $8.75 million for fiscal year 2025.
IGC Pharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $8.75M | -11.7% |
| 2024 | $9.90M | -42.4% |
| 2023 | $17.18M | -36.0% |
| 2022 | $26.83M | -25.2% |
| 2021 | $35.87M | +23.7% |
| 2020 | $28.98M | -15.9% |
| 2019 | $34.47M | +217.6% |
| 2018 | $10.85M | -3.8% |
| 2017 | $11.28M | -40.2% |
| 2016 | $18.86M | -7.2% |
| 2015 | $20.33M | +14.6% |
| 2014 | $17.73M | -7.9% |
| 2013 | $19.25M | -23.8% |
| 2012 | $25.26M | +39.1% |
| 2011 | $18.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.74M | -6.0% | +22.7% |
| June 30, 2025 | $7.94M | -25.0% | -9.2% |
| March 31, 2025 | $8.75M | -11.7% | -3.6% |
| December 31, 2024 | $9.08M | -19.4% | -12.5% |
| September 30, 2024 | $10.37M | -37.2% | -2.1% |
| June 30, 2024 | $10.59M | -32.4% | +7.0% |
| March 31, 2024 | $9.90M | -42.4% | -12.1% |
| December 31, 2023 | $11.26M | -43.9% | -31.8% |
- IGC Pharma, Inc. showed a decrease of -11.7% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, IGC Pharma, Inc.’s total assets has declined by 51.8% (from $18.16 million to $8.75 million).
- The most recent figure is from IGC Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: